Market Expert Sudip Bandyopadhyay Reveals His Top Pharma Bets For The Next Big Rally

India's pharmaceutical and healthcare sectors continue to offer strong long-term investment opportunities across multiple segments. Sudip Bandyopadhyay, Market Expert, shares his preferred picks spanning domestic pharma, CDMO companies, and hospital businesses. He believes the sector's growth is backed by rising healthcare demand, expanding manufacturing capabilities, and improving industry fundamentals. While acknowledging that valuations remain premium, he says quality businesses can continue to deliver over the long term. Sudip also highlights that investors who look beyond the most popular names and focus on strong fundamentals may find attractive opportunities in India's rapidly evolving pharma and healthcare ecosystem.